经皮肾镜取石术与逆行肾内手术治疗肾结石:一项Cochrane系统评价
该Cochrane系统评价比较经皮肾镜取石术(PCNL)与逆行肾内手术(RIRS)治疗成人肾结石的效果,纳入42项试验。PCNL可能提高无石率(RR 1.13,95%CI 1.08-1.18,低证据质量),可能减少二次干预需求(RR 0.31,95%CI 0.17-0.55,低证据质量),对主要并发症可能几乎无影响(RR 0.86,95%CI 0.59-1.25,中等证据质量)。
要点
- PCNL可能提高无石率(RR 1.13,95%CI 1.08-1.18,低证据质量)。
- PCNL可能减少二次干预需求(RR 0.31,95%CI 0.17-0.55,低证据质量)。
- PCNL对主要并发症可能几乎无影响(RR 0.86,95%CI 0.59-1.25,中等证据质量)。
核心结论
- 尽管多数研究存在缺陷使证据质量多为极低或低,PCNL可能提高无石率并减少二次干预需求,且不影响主要并发症。
- 与RIRS相比,输尿管狭窄率可能相似。
- 作者认为该评价结果有助于肾结石患者管理选择的共享决策。
研究设计与样本
- Cochrane系统评价,全面检索Cochrane Library、MEDLINE、Embase等数据库及灰色文献和会议论文集,截止2023年3月23日,无语言或发表状态限制。
- 由两名独立评价者重复进行筛选、数据提取、偏倚风险评估,并使用GRADE方法评定证据质量。
- 纳入42项符合纳入标准的试验。
主要发现
- 无石率:PCNL可能提高无石率(RR 1.13,95%CI 1.08-1.18;I²=71%;39项研究,4088名参与者;低证据质量)。
- 主要并发症:与RIRS相比,PCNL对主要并发症可能几乎无影响(RR 0.86,95%CI 0.59-1.25;I²=15%;34项研究,3649名参与者;中等证据质量)。
- 二次干预需求:与RIRS相比,PCNL可能减少二次干预需求(RR 0.31,95%CI 0.17-0.55;I²=61%;21项研究,2005名参与者;低证据质量)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 多数研究存在缺陷,使效应估计的证据质量多为极低或低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the effects of percutaneous nephrolithotomy (PCNL) vs retrograde intrarenal surgery (RIRS) for the treatment of renal stones in adults. METHODS: We performed a comprehensive search of the Cochrane Library, MEDLINE, Embase, three other databases, trials registries, other sources of the grey literature, and conference proceedings up to 23 March 2023. We applied no restrictions on publication language or status. Screening, data extraction, risk-of-bias assessment, and certainty of evidence (CoE) rating using the Grading of Recommendations Assessment, Development and Evaluations (GRADE) approach were done in duplicate by two independent reviewers. This co-publication focuses on the primary outcomes of this review only. RESULTS: We included 42 trials that met the inclusion criteria. Stone-free rate (SFR): PCNL may improve SFRs (risk ratio [RR] 1.13, 95% confidence interval [CI] 1.08-1.18; I2 = 71%; 39 studies, 4088 participants; low CoE). Major complications: PCNL probably has little to no effect on major complications (RR 0.86, 95% CI 0.59-1.25; I2 = 15%; 34 studies, 3649; participants; moderate CoE) compared to RIRS. Need for secondary interventions: PCNL may reduce the need for secondary interventions (RR 0.31, 95% CI 0.17-0.55; I2 = 61%; 21 studies, 2005 participants; low CoE) compared to RIRS. CONCLUSION: Despite shortcomings in most studies that lowered our certainty in the estimates of effect to mostly very low or low, we found that PCNL may improve SFRs and reduce the need for secondary interventions while not impacting major complications. Ureteric stricture rates may be similar compared to RIRS. We expect the findings of this review to be helpful for shared decision-making about management choices for individuals with renal stones.
引用
- Soderberg L, Ergun O, Ding M, et al. Percutaneous nephrolithotomy vs retrograde intrarenal surgery for renal stones: a Cochrane Review. BJU Int. 2023. PMID: 37942649. doi:10.1111/bju.16220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。